Abstract
Background
Many newly screened people living with HIV (PLHIV) in Sub-Saharan Africa do not understand the importance of regular pre-antiretroviral (ARV) care because most of them have been counseled by staff who lack basic counseling skills. This results in low uptake of pre-ARV care and late treatment initiation in resource-poor settings. The effect of providing post-test counseling by staff equipped with basic counseling skills, combined with home visits by community support agents on uptake of pre-ARV care for newly diagnosed PLHIV was evaluated through a randomized intervention trial in Uganda.
Methods
An intervention trial was performed consisting of post-test counseling by trained counselors, combined with monthly home visits by community support agents for continued counseling to newly screened PLHIV in Iganga district, Uganda between July 2009 and June 2010, Participants (N = 400) from three public recruitment centres were randomized to receive either the intervention, or the standard care (the existing post-test counseling by ARV clinic staff who lack basic training in counseling skills), the control arm. The outcome measure was the proportion of newly screened and counseled PLHIV in either arm who had been to their nearest health center for clinical check-up in the subsequent three months +2 months. Treatment was randomly assigned using computer-generated random numbers. The statistical significance of differences between the two study arms was assessed using chi-square and t-tests for categorical and quantitative data respectively. Risk ratios and 95% confidence intervals were used to assess the effect of the intervention.
Results
Participants in the intervention arm were 80% more likely to accept (take up) pre-ARV care compared to those in the control arm (RR 1.8, 95% CI 1.4-2.1). No adverse events were reported.
Conclusions
Provision of post-test counseling by staff trained in basic counseling skills, combined with home visits by community support agents had a significant effect on uptake of pre-ARV care and appears to be a cost-effective way to increase the prerequisites for timely ARV initiation.
Trial registration
The trial was registered by Current Controlled Trials Ltd C/OBioMed Central Ltd as ISRCTN94133652 and received financial support from Sida and logistical support from the European Commission.
You have requested "on-the-fly" machine translation of selected content from our databases. This functionality is provided solely for your convenience and is in no way intended to replace human translation. Show full disclaimer
Neither ProQuest nor its licensors make any representations or warranties with respect to the translations. The translations are automatically generated "AS IS" and "AS AVAILABLE" and are not retained in our systems. PROQUEST AND ITS LICENSORS SPECIFICALLY DISCLAIM ANY AND ALL EXPRESS OR IMPLIED WARRANTIES, INCLUDING WITHOUT LIMITATION, ANY WARRANTIES FOR AVAILABILITY, ACCURACY, TIMELINESS, COMPLETENESS, NON-INFRINGMENT, MERCHANTABILITY OR FITNESS FOR A PARTICULAR PURPOSE. Your use of the translations is subject to all use restrictions contained in your Electronic Products License Agreement and by using the translation functionality you agree to forgo any and all claims against ProQuest or its licensors for your use of the translation functionality and any output derived there from. Hide full disclaimer
Details
1 Iganga District Administration, District Health Office, Iganga, Uganda; Makerere University Iganga/Mayuge Health & Demographic Surveillance System, Kampala, Uganda (GRID:grid.11194.3c) (ISNI:0000000406200548); IHCAR, Division of Global Health, Department of Public Health Sciences Karolinska Institutet, Sweden (GRID:grid.11194.3c); Makerere University School of Public Health, Department of Health Policy Planning and Management, Kampala, Uganda (GRID:grid.11194.3c) (ISNI:0000000406200548); Institute of Health Sciences Busoga University, Iganga, Uganda (GRID:grid.442629.f)
2 Makerere University School of Public Health, Department of Epidemiology and Biostatistics, Kampala, Uganda (GRID:grid.11194.3c) (ISNI:0000000406200548)
3 Makerere University Iganga/Mayuge Health & Demographic Surveillance System, Kampala, Uganda (GRID:grid.11194.3c) (ISNI:0000000406200548)
4 IHCAR, Division of Global Health, Department of Public Health Sciences Karolinska Institutet, Sweden (GRID:grid.11194.3c)
5 Makerere University School of Public Health, Department of Health Policy Planning and Management, Kampala, Uganda (GRID:grid.11194.3c) (ISNI:0000000406200548)
6 IHCAR, Division of Global Health, Department of Public Health Sciences Karolinska Institutet, Sweden (GRID:grid.11194.3c); Uppsala University, IMCH, Department of Women's and Children's Health, Sweden (GRID:grid.8993.b) (ISNI:0000000419369457)
7 IHCAR, Division of Global Health, Department of Public Health Sciences Karolinska Institutet, Sweden (GRID:grid.8993.b); Karolinska University Hospital, Department of Infectious Diseases, Sweden (GRID:grid.24381.3c) (ISNI:0000000092415705)




